Entrada Therapeutics Inc (TRDA)

Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.63%0.90	0.88	1.30	1.61	1.95
	6.21%45.86	43.18	43.51	48.67	48.80
Research and Development	7.00%35.37	33.05	33.96	38.36	37.88
Operating Income/Loss	6.29%-44.96	-42.30	-42.21	-47.05	-46.85
Income Tax Expense/Benefit	7.89%0.04	0.04	0.09	0.65	0.18
	7.67%-42.76	-39.72	-39.16	-44.13	-43.10
Attributable To Parent	7.67%-42.76	-39.72	-39.16	-44.13	-43.10
Basic Average Shares	0.92%42.22	41.84	0.08	41.46	41.34
Diluted Average Shares	0.92%42.22	41.84	0.08	41.46	41.34
Basic Earnings Per Share	6.32%-1.01	-0.95	-0.94	-1.06	-1.04
Diluted Earnings Per Share	6.32%-1.01	-0.95	-0.94	-1.06	-1.04